Streamlining eligibility assessment for Alzheimer's disease-modifying therapies: Prediction of MMSE scores using the digital clock and recall

IntroductionThe eligibility of anti-amyloid disease-modifying therapies (DMTs) and their integration into clinical practice in some institutions requires a specific range of Mini-Mental State Examination (MMSE) scores. Reliance on this pencil-and-paper psychometric instrument imposes operational bur...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ali Jannati, Claudio Toro-Serey, Marissa Ciesla, Emma Chen, John Showalter, David Bates, Alvaro Pascual-Leone, Sean Tobyne
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2026-07-01
Saila:	Frontiers in Digital Health
Gaiak:	Alzheimer's disease dementia digital clock and recall digital cognitive assessment disease-modifying treatment machine learning
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fdgth.2026.1799372/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!